“Latest Stem Cells News”

Italy’s Constitutional Court relaxed parts of a law on artificial procreation that had imposed strict rules for fertility treatments.
The judges struck down as unconstitutional one of the most contested sections of the 2004 law, which said only three embryos could be created at one time, and all had to be implanted in the patient’s womb, a court spokesman said.

The judges also introduced stronger wording to ensure that embryos are implanted only if it doesn’t endanger the woman’s health, said spokesman Giovanni Gattarino.
The issue had been put before the constitutional judges by lower administrative and civil courts, which have been considering cases brought against the law by several couples, Gattarino said.

A biopolymer could aid in the regrowing of nerves induced by the use of stem cells according to a new research project that gives hope to people who have been in an accident and have lost the use of one or more limbs. The procedure will enter into clinical testing in January after animal testing has been completed.
The Experimental Neurological Institute (INSPE), founded in 2005 at San Raffaele Hospital of Milan became operational with the inauguration of more than 1,200 square meters of lab space entirely dedicated to general and clinical research therapies for serious neurological diseases, like multiple sclerosis, strokes, spinal trauma, and peripheral neuropathy.
Director Giancarlo Comi, the head of the Department of Neurology at San Raffaele said, “Until now, when trying to induce nerves to grow back we were using veins that had the defect of being empty internally.”

According to the European Patent Office, there will be no patents in Europe for embryonic stem cells. The board decided to fully uphold a sentence from June by a select committee regarding a request for a patent made by the Wisconsin Alumni Research Foundation, based at the University where James Thompson, the scientist who discovered stem cells, works. “European patent law prohibits the application of patents to stem cell cultures whose preparation necessarily implicates the destruction of human embryos.”

Giancarlo Comi

A biopolymer could aid in the regrowing of nerves induced by the use of stem cells according to a new research project that gives hope to people who have been in an accident and have lost the use of one or more limbs. The procedure will enter into clinical testing in January after animal testing has been completed.

The Experimental Neurological Institute (INSPE), founded in 2005 at San Raffaele Hospital of Milan became operational with the inauguration of more than 1,200 square meters of lab space entirely dedicated to general and clinical research therapies for serious neurological diseases, like multiple sclerosis, strokes, spinal trauma, and peripheral neuropathy.